A doctor who supervised testing of an Alzheimer’s disease drug said he was 'flabbergasted' and 'shocked' at the precise information that former SAC Capital Advisors fund manager Mathew Martoma had about the drug trial results.
Bloomberg reports that Joel Ross, 58, a New Jersey geriatric specialist, testified in Martoma’s insider-trading trial yesterday about a July 28th, 2008, meeting with the fund manager in the lobby of a Chicago hotel. Moments earlier, the physician had left a meeting in which researchers learned of the trial’s results.
'It was like he was in the room with me, with the slides I had just seen', Ross told jurors in Manhattan federal court.
Ross, who testified over the last two days, is one of two doctors who prosecutors say passed confidential data to Martoma, 39, about a Phase 2 clinical trial of the drug bapineuzumab. At the time of Martoma’s meeting with Ross, former University of Michigan neurologist Sid Gilman had already given him the results, prosecutors say.
To access the complete Bloomberg article hit the link below:
image: © Clyde Robinson